ATE424396T1 - Neue aryl-4-halogen-4- (heteroarylmethylamino)methyl piperidin-1-yl- methanonderivate, herstellungsverfahren und deren verwendung als medikamente - Google Patents

Neue aryl-4-halogen-4- (heteroarylmethylamino)methyl piperidin-1-yl- methanonderivate, herstellungsverfahren und deren verwendung als medikamente

Info

Publication number
ATE424396T1
ATE424396T1 AT03760060T AT03760060T ATE424396T1 AT E424396 T1 ATE424396 T1 AT E424396T1 AT 03760060 T AT03760060 T AT 03760060T AT 03760060 T AT03760060 T AT 03760060T AT E424396 T1 ATE424396 T1 AT E424396T1
Authority
AT
Austria
Prior art keywords
heteroarylmethylamino
medications
halogen
production process
methyl piperidine
Prior art date
Application number
AT03760060T
Other languages
English (en)
Inventor
Bernard Vacher
Bernard Bonnaud
Jean-Louis Maurel
Francis Colpaert
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE424396T1 publication Critical patent/ATE424396T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT03760060T 2002-06-18 2003-06-18 Neue aryl-4-halogen-4- (heteroarylmethylamino)methyl piperidin-1-yl- methanonderivate, herstellungsverfahren und deren verwendung als medikamente ATE424396T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0207470A FR2840900B1 (fr) 2002-06-18 2002-06-18 Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments

Publications (1)

Publication Number Publication Date
ATE424396T1 true ATE424396T1 (de) 2009-03-15

Family

ID=29595331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03760060T ATE424396T1 (de) 2002-06-18 2003-06-18 Neue aryl-4-halogen-4- (heteroarylmethylamino)methyl piperidin-1-yl- methanonderivate, herstellungsverfahren und deren verwendung als medikamente

Country Status (15)

Country Link
US (1) US7547700B2 (de)
EP (1) EP1539738B1 (de)
JP (1) JP4699027B2 (de)
CN (1) CN1308325C (de)
AT (1) ATE424396T1 (de)
AU (1) AU2003258816B2 (de)
BR (1) BRPI0311976B8 (de)
CA (1) CA2489723C (de)
DE (1) DE60326468D1 (de)
ES (1) ES2321927T3 (de)
FR (1) FR2840900B1 (de)
HK (1) HK1075452A1 (de)
MX (1) MXPA05000024A (de)
WO (1) WO2003106449A1 (de)
ZA (1) ZA200500467B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852244B1 (fr) * 2003-03-13 2007-09-07 Pf Medicament Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene
FR2891274B1 (fr) * 2005-09-27 2007-11-23 Pierre Fabre Medicament Sa Procede de preparation du (3-chloro-4-fluoro-phenyl)-(4- fluoro-4-{[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl}- piperidin-1-yl)-methanone et nouveaux derives pyrimidiniques intermediaires.
JP2011520975A (ja) * 2008-05-19 2011-07-21 ユニヴァーシティ オブ テネシー リサーチ ファウンデーション，ザ ピリミジンの非古典的カンナビノイド化合物及び関連する使用方法
US8389534B2 (en) * 2008-05-19 2013-03-05 The University Of Tennessee Research Foundation Pyrimidine non-classical cannabinoid compounds and related methods of use
FR2946344B1 (fr) * 2009-06-05 2012-05-25 Pf Medicament Nouveaux derives d'aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl} methanone, leur procede de preparation et leur utilisation a titre de medicaments
EP2338873A1 (de) 2009-12-22 2011-06-29 Gmeiner, Peter Neue Aminotetralinderivate
US10626105B2 (en) 2016-09-22 2020-04-21 Auspex Pharmaceuticals, Inc. Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds
EP3664787B1 (de) 2017-07-20 2022-07-20 Neurolixis Verwendung von selektiven serotin-5-ht1a-rezeptor-agonisten zur behandlung von nebenwirkungen von vmat-inhibitoren
WO2023144166A1 (en) 2022-01-26 2023-08-03 Neurolixis Use of serotonin 5-ht1a receptor agonists to treat diseases associated with sudden unexpected death in epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN169588B (de) * 1986-10-07 1991-11-16 Pfizer Hospital Prod
FR2755967B1 (fr) * 1996-11-21 1999-01-29 Pf Medicament Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
FR2784378B1 (fr) * 1998-10-09 2000-12-29 Pf Medicament Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments
FR2820743B1 (fr) * 2001-02-09 2005-02-25 Pf Medicament Procede et intermediaires de synthese pour la preparation de derives de pyridin-2-yl-methylamine

Also Published As

Publication number Publication date
AU2003258816A1 (en) 2003-12-31
BRPI0311976B1 (pt) 2015-08-18
CA2489723A1 (fr) 2003-12-24
FR2840900A1 (fr) 2003-12-19
HK1075452A1 (en) 2005-12-16
ZA200500467B (en) 2005-12-28
US20060100244A1 (en) 2006-05-11
MXPA05000024A (es) 2005-04-08
ES2321927T3 (es) 2009-06-15
DE60326468D1 (de) 2009-04-16
BR0311976A (pt) 2005-03-29
WO2003106449A8 (fr) 2005-02-17
CN1308325C (zh) 2007-04-04
EP1539738A1 (de) 2005-06-15
CN1675194A (zh) 2005-09-28
FR2840900B1 (fr) 2005-02-25
AU2003258816B2 (en) 2008-08-21
BRPI0311976B8 (pt) 2021-05-25
JP2005534668A (ja) 2005-11-17
EP1539738B1 (de) 2009-03-04
CA2489723C (fr) 2011-08-02
WO2003106449A1 (fr) 2003-12-24
JP4699027B2 (ja) 2011-06-08
US7547700B2 (en) 2009-06-16

Similar Documents

Publication Publication Date Title
HK1075452A1 (en) Novel aryl- 4-halo-4- heteroarylmethylamino)-methyl -piperidin-1-yl - methanone derivatives, methods for production and use thereof as medicaments
MXPA05004188A (es) Antagonistas de cgrp elegidos, procedimiento para su preparacion, asi como su empleo como medicamentos.
RS20050311A (en) Selected cgrp antagonists,method for production and use thereof as medicament
ATE430150T1 (de) 8-ä3-amino-piperidin-1-ylü-xanthine, deren herstellung und deren verwendung als dpp-iv hemmer
CY1109510T1 (el) Επιλεγμενοι ανταγωνιστες toy cgrp, μεθοδος για την παραγωγη τους και για τη χρηση τους ως φαρμακων
CL2010000204A1 (es) Compuestos intermediarios derivados de 4 amino-3-metoxibenzamida; compuesto intermediario n-{4-[4-(ciclopropilmetil)piperazin-1-il]ciclohexil}acetamida; compuesto intermediario 2-cloro-7-etil-7,8-dihidro-5-metil-8-(1-metiletil)-6(5h)-pteridinona, útiles en la preparación de dihidropteridinonas sustituidas (divisional sol. 2077-05).
WO2005103037A3 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
NO20064669L (no) Dipeptidylpeptidaseinhibitorer
ATE373009T1 (de) Verfahren zur vorbereitung von telithromycin
ATE444747T1 (de) Verfahren zur herstellung von expoxybutanol- zwischenprodukten
ATE422198T1 (de) Arylsulfonylnaphthalinderivate als 5ht2a- antagonisten
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
NO20072872L (no) Kjemisk prosess
TR200103490T2 (tr) Antihistaminik ve antialerjik maddeler olarak indolilpiperidin türevleri
ATE518835T1 (de) Kristallform einer chinolinverbindung und verfahren zu deren herstellung
ATE525364T1 (de) Verfahren zur herstellung von 3,6-dihydro-1,3,5- triazin-derivaten
CY1107101T1 (el) Μεθοδος συνθεσης παραγωγων της 1,3-διϋδρο-2h-3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης με φαρμακευτικως αποδεκτο οξυ
DE602005010369D1 (de) 2-thiaquinolizidines als Glycosidase- und Glycosyltransferase-Inhibitoren
DE60335865D1 (de) Verfahren zur herstellung von cilostazol
CO6150165A2 (es) Nevos derivados 5,7-disustituidos de [1,3]tiazolo[4,5-d]pirimidin-2 (3h)-ona y su uso en terapia
MX2008000821A (es) Nuevos derivados de piperidina.
UA90131C2 (en) Method for the production of losartan
NL1025072A1 (nl) Complexen van E-2-methoxy-N-(3-{4-[3-methyl-4-(6-methylpyridin-3-yloxy)-fenylamino]- chinazolin-6-yl}-allyl)-aceetamide, werkwijze voor de productie ervan, en toepassing.
DE60323748D1 (de) 1,3-diaza-dibenzoazulene als inhibitoren der produfür deren herstellung
ATE444964T1 (de) 5-pyridinyl-1-azabicycloä3.2.1üoctan-derivate, herstellungsverfahren und deren verwendung für therapeutika

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties